Fulgent Genetics rises after FY revenue forecast raise, Q3 revenue beat

Shares of genetic testing company Fulgent Genetics FLGT.O rise 7.6% to $24 premarket

Co raises FY revenue forecast to $325 million, compared to a previous view of $320 million, analysts expect annual revenue of $320.12 million as per LSEG-compiled data

Co posts Q3 revenue of $84.07 million, vs an estimate of $81.4 million

As of last close, FLGT stock was up 20.8% YTD